Literature DB >> 22407189

Histological evaluation of rat larynx in experimental polycystic ovary syndrome model.

Hande Senem Deveci1, Ildem Deveci, Mehmet Habesoglu, Mehmet Sürmeli, Vefa Kınıs, Murat Eriman, Pembegul Gunes, Murat Yekrek, Erol Egeli.   

Abstract

This study aimed at studying the histopathological effects of hyperandrogenemia and estrogen deficiency on larynx mucosa in experimentally designed polycystic ovary syndrome of female rats. Two groups of experimental polycystic ovary syndrome model were composed in healthy female rats by per oral letrozole administration of for 21 and 42 days. Also a control group which only took vehicle (saline) for 42 days was designed. Laryngeal mucosa and ovaries of all animals were examined histopathologically by light microscopy and the serum hormone levels were analyzed using a solid-phase, two-site chemiluminescent enzyme immunometric assay. Statistically significant edema, vascular engorgement, inflammation, cilia loss and differentiation of goblet cell distribution were observed when the control group and study groups were compared (p < 0.01). In serum hormonal analysis there was a significant increase in levels of androgens and decrease in levels of estrogens. In addition, polycystic appearance of ovaries in letrozole-administered groups and normal appearance of ovaries in control group have been proven histopathologically. Polycystic ovary syndrome which causes estrogen deficiency and hyperandrogenemia in fertile ages resulted in histopathological changes in laryngeal mucosa.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407189     DOI: 10.1007/s00405-012-1978-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  26 in total

1.  Preliminary report on hormone receptors in the human vocal fold.

Authors:  S R Newman; J Butler; E H Hammond; S D Gray
Journal:  J Voice       Date:  2000-03       Impact factor: 2.009

2.  Auditory brain stem response throughout the menstrual cycle.

Authors:  Agostino Serra; Luigi Maiolino; Carmela Agnello; Agostino Messina; Salvatore Caruso
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-06       Impact factor: 1.547

3.  Effects of patch or gel estrogen therapies on auditory brainstem response in surgically postmenopausal women: a prospective, randomized study.

Authors:  Salvatore Caruso; Luigi Maiolino; Carmela Agnello; Aldo Garozzo; Lucia Di Mari; Agostino Serra
Journal:  Fertil Steril       Date:  2003-03       Impact factor: 7.329

4.  Histologic and histochemical study of effects of anabolic steroids on the female larynx.

Authors:  M Talaat; A M Talaat; I Kelada; A Angelo; S Elwany; H Thabet
Journal:  Ann Otol Rhinol Laryngol       Date:  1987 Jul-Aug       Impact factor: 1.547

Review 5.  Persistent estrus rat models of polycystic ovary disease: an update.

Authors:  Krishna B Singh
Journal:  Fertil Steril       Date:  2005-10       Impact factor: 7.329

6.  Towards the expression of sex hormone receptors in the human vocal fold.

Authors:  Berit Schneider; Eleonore Cohen; Josefine Stani; Andrea Kolbus; Margarethe Rudas; Reinhard Horvat; Michael van Trotsenburg
Journal:  J Voice       Date:  2006-03-29       Impact factor: 2.009

7.  Growth of the human prepubertal and pubertal larynx.

Authors:  J C Kahane
Journal:  J Speech Hear Res       Date:  1982-09

Review 8.  Studies of human olfaction from the University of Pennsylvania Smell and Taste Center.

Authors:  R L Doty
Journal:  Chem Senses       Date:  1997-10       Impact factor: 3.160

9.  Noneosinophilic CD4 lymphocytic airway inflammation in menopausal women with chronic dry cough.

Authors:  Ester Mund; Birger Christensson; Reidar Grönneberg; Kjell Larsson
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

10.  Comparison of the effects of letrozole and clomiphene citrate on ovarian follicles, endometrium, and hormone levels in the rat.

Authors:  Tulay Kilic-Okman; Mustafa Kucuk; Semsi Altaner
Journal:  Fertil Steril       Date:  2003-12       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.